I object to calling it AIDS, specifically because I remember treating AIDS patients who had specific illnesses associated with the specific immune compromise resulting from lower CD4 cell counts. These infections were "opportunistic" in the sense that the possibility of suffering from these illnesses are ever-present, but they only show up as a result of sufficient immune compromise. The particular cancers that Dr. Cole is finding are not unusual in this same way that the illnesses we saw with AIDS were. They may be more aggressive tumors, but they aren't notably unusual tumors. If they were, this problem would have been noted by physicians who are not keen on seeing vaccine adverse events (let's call them "normie doctors" for lack of a better term).

Don't allow the "normie doctors" to dismiss these claims by throwing around the term AIDS, which is inextricably connected to HIV. VAIDS is not much better.

By the way, I'm listed as a co-author on the important early treatment study by Dr. Peter McCullough (author #7 here: https://pubmed.ncbi.nlm.nih.gov/33387997/) so I'm not an adversary.